chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Soreness on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness on the left arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included Elbow injury and Laser therapy on 26-Mar-2021.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness on the left arm). At the time of the report, VACCINATION SITE PAIN (Soreness on the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Patient mentioned that he has been receiving laser therapy by a physical therapist for months for his elbow injury that occurred an year back. Patient never had PRP injection but was advised by healthcare professional to promote healing to the elbow. Patient mentioned that he has a scheduled laser therapy in ten days.
I had a really scary dizzy spell that has never happened before. I was in class virtually and the room was spinning so badly that I had to cover my face and yell tor for help. I really felt that I was going to faint out of nowhere onto the floor from my seat. There wasn't any pain, just feeling faint and lightheaded the rest of the day.
pt recvd vax & became weak instructed to sit in waiting room for 10-20 mins for observation;called later in day w/report of 2 1/2 diameter reddened area;no swelling;no SOB;if worse report to ER
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Medium, Additional Details: Pt described becoming violently ill after receiving 1st dose to the point he believed he would need to go to the hospital. N/V, weakness, migraine. Residually has felt nerve pain/tingling, almost as if left arm/leg fall asleep very slowly and he has to wake them up. Very concerned about the numbing feeling
Tested positive on at-home test for Covid-19 on 11/1/22 after displaying symptoms. Began Paxlovid 11/2/22. Ill and off work for 1 week. Back to work 11/8/22 with lasting lethargy, dizziness, sore throat/chest.
4 days of a stiff  and immovable neck, sore lymph nodes in neck, base of skull & clavicle bone, swollen throat with difficulty swallowing, unable to sleep for 3 nights!
Received the wrong vaccine product, received the 5-11y old not the appropriate 12 yr. and older vaccine. No adverse effects noted.
I began to experience Pulsatile Tinnitus in my right ear; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Nov2022 as dose 4 (booster), single (Lot number: GJ3275) at the age of 22 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Migraines" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Convergence insufficiency" (unspecified if ongoing); "If COVID prior vaccination: Yes" (unspecified if ongoing), notes: If COVID prior vaccination: Yes. The patient's concomitant medications were not reported. Past drug history included: Clindamycin, reaction(s): "known allergies: Clindamycin", notes: known allergies: Clindamycin. Vaccination history included: Covid-19 vaccine (Dose number: 1, Manufacturer: Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose number: 2, Manufacturer: Unk2own), for COVID-19 immunization; Covid-19 vaccine (Dose number: 3, Manufacturer: Unknown), for COVID-19 immunization. The following information was reported: TINNITUS (non-serious) with onset 22Nov2022 at 12:00, outcome "not recovered", described as "I began to experience Pulsatile Tinnitus in my right ear". The event "i began to experience pulsatile tinnitus in my right ear" required physician office visit. Therapeutic measures were not taken as a result of tinnitus. Additional information: The patient had COVID prior vaccination. The patient had not COVID tested post vaccination.
experiencing severe headaches; sore arm 5 min after they got it (vaccination); This spontaneous case was reported by an other and describes the occurrence of HEADACHE (experiencing severe headaches) and VACCINATION SITE PAIN (sore arm 5 min after they got it (vaccination)) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023MZ0A) for COVID-19 vaccination.     Concomitant products included MINOXIDIL.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced HEADACHE (experiencing severe headaches) and VACCINATION SITE PAIN (sore arm 5 min after they got it (vaccination)). On 20-Feb-2021, VACCINATION SITE PAIN (sore arm 5 min after they got it (vaccination)) had resolved. On 26-Feb-2021, HEADACHE (experiencing severe headaches) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No treatment details were provided.    Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: No specific follow-up information recorded.
Sore arm; tired; feels a little weak; This is a spontaneous report received from a non-contactable consumer (patient) via company representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), on unspecified date as unknown, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm, tired and he/she felt a little weak. The events took place after the use of the product. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt had a pneumonia vaccination given by her rheumatologist on Monday Aug 13th. Pt reported to Dr. on August 16th at our walk in clinic, sore arm. Large raised reddened area at injection site that appears to be outside the normal paramaters for vaccine injections into the muscle.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed a total of 12 pox. The pt had a fever for 2 days. The rash began on her forehead and face and spread to the rest of her body. Fourteen days post onset the pt recovered. this was considered to be a case of mild breakthrough chickenpox.
Arm is hurting at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is hurting at the injection site) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03AB21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE PAIN (Arm is hurting at the injection site). At the time of the report, VACCINATION SITE PAIN (Arm is hurting at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was not under any medication.  It was reported that patient's arm was hurting at injection site from the night of 12-Apr-2021 and was hurting at the time of reporting.  The patient did not receive any treatment for the symptom.
Information has been received from a pharmacist and technician concerning a 66 year old female with allergic reaction to quinolones and no reported medical history who on 05-SEP-2007 was vaccinated with Zostavax (lot # 658085/0882U). Concomitant therapy included a steroid injection and other unspecified medications. On 07-SEP-2007 the patient experienced fever, swelling and redness at the injection site. The patient sought the medical attention of the pharmacist. On 14-SEP-2007 the patient contacted the pharmacy and reported that she was admitted to the hospital on 11-SEP-2007 for a "mini-stroke". She was released on 13-SEP-2007. The patient is recovering from her events. Additional information has been requested.
Information has been received from the pt's mother concerning her 20 week old white daughter who on 06-SEP-2000 at 1:20 PM was vaccinated in the left arm with a second dose of Comvax. Concomitant therapy included a second dose in the left arm of DTP, a first dose in the left arm of Prevnar and a second dose in the left arm of IPOL. The pt's other reported that she then developed hives and difficulty breathing. She was given Benadryl for the hives and the symptoms went away. Follow up information has been received from a physician who reported that on 06-SEP-2000, the pt experienced a mild local reaction with a spreading red macular rash around the Comvax injection site. The rash spread from the face the the abdomen. It was noted that the pt had no distress and no respiratory difficulties. It was also noted that the pt was treated with 1/4 teaspoonful of Benadryl and the rash decreased significantly in ten minutes. No lab tests were done and the pt recovered. no further information is available.
Complaint of bilateral armpit pain.   Pain started the day after vaccine. Pain in R axilla actually was more sharp and the pain in the L axilla is more sore and achy.  She denies any pain elsewhere of symptoms of systemic illness.
VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of drug exposure during pregnancy in a 31-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis while pregnant.   There were no concurrent medications.   On 20 December 2010 at 11:20 the subject received 1st dose of Boostrix at 0.5 ml inthe left arm. The subject experienced drug exposure during pregnancy. Her date of last menstrual period was not reported and her estimated date of delivery was 28 March 2011. No adverse events were noted at the time of reporting.  Upon internal review done on 13th September 2019, the pregnancy outcome was updated to lost to follow-up.
Pt. states that after receiving the 2nd dose of Moderna 03/26/2021, started experiencing symptoms 04/01/2021 of short-term memory loss.
This spontaneous report as received from a Medical Assistant refers to an unspecified number of patients of unknown age and gender. On an unspecified date in March 2014, the patients were vaccinated with GARDASIL that on 14-MAR-2014 were exposed to 52F for 17 hours (dose, route and lot numbers were not reported). Concomitant medications were not reported. No adverse effects reported. This case is linked to cases 1404USA004081, 1404USA004082 and 1404USA004083 via same reporter link. Additional information has been requested.
Red rash and itching at site of injection at end of 7th day of receiving the injection continuing today which is the 9th day. It's about 1.5-2" in diameter Dizziness this morning when getting up -- could be I'm dehydrated. Went away after resting and hydrating with boiled rice water. Tiny feeling of head cold. But no runny nose, no fever, no cough.
Flu vaccination 10/04/2004 left deltoid. PC 10/27/04 complaints of soreness left arm with weakness. States it started the day of the injection. States he is unable to raise his arm above chest when holding it in front of him. states it's getting worse last couple of days.
Mild headache for most of the day, somewhat worse in the evening. Went away by the next morning.
Patient received her first dose of the Pfizer COVID  vaccine on 7/14 and noticed adverse reaction on 7/15. Patient reports pimples that are itchy all over her body (arm, back, neck, and leg). Patient does not have any trouble breathing. She does report involuntary movement of fingers on her left hand. Patient was then counseled to take Loratadine.
Fainted. Lasted only seconds, was sitting at the time. Had also had finger poke for hemoglobin. No injury occurred.
Severe headache, vomiting, diarrhea, body aches, very painful arm and shoulder on injection side, shaking chills, and fatigue that kept me in bed for 5- 6 eats
Pre-existing complex regional pain syndrome in left lower extremity. Three days following flu shot he presented with pain, swelling, mottling, decreased temp., of his right upper extremity from mid forearm distal to entire hand. Vaccine was given in left deltoid.
Admitted to hospital for fatigue and SOB for 2 weeks, and found to be very hypoxic.  Placed on BiPAP.  She was placed on remdesivir and Decadron, was not a candidate for baricitinib because of low absolute lymphocyte count.  She was transferred to hospital.  She was given IVIG d/t her immune suppressed status.  Patient made herself DNR on 02/08/2022 after discussion with pulmonary.  Patient finished dexamethasone and remdesivir course.  Patient continued to require high amounts of oxygen and was noted to be desaturating with minimal mobility and movement.   Patient was consulted by palliative care and moved to ICU for closer monitoring.  Patient expired on 02/17/2022.
Patient had Hepatitis B vaccine @ 10:30 am this morning.   Around 2:00 pm this afternoon patient become ill with emesis, rash on leg, sharp pain in abdomen.    Pt has taken benadryl in the past with no reaction.  She will take for the rash on her leg.   She will alternate Tylenol and ibuprofen for her pain.  Will increase hydration.   She has no fever/chills/tongue swelling/trouble breathing-swallowing.  If she develops any worsening sxs over the night she will go to the ED.
rec'd 3rd dose, pt was asked several times if this was their 2nd dose and he said yes. our record indicated he only had 1.
A few hours after injection,  had a sore arm and slight headache. The next morning, arm was extremely sore and hurt to move. That evening I had the first migraine that I've ever had. In the month since the injection, I have not menstruated which is not normal for me. I have also had a dry cough off and on and pain in my fingers and hands like arthritis
Fever (101 degrees), pain in Bilateral legs (Patient receive shots in both legs) some swelling at inj. sites.
I TESTED POSITIVE FOR COVID ON 07/10/2021. I HAD CONGESTION IN MY NOISE LIKE A COLD. IT STARTED JULY 7, 2021 UNTIL JULY 12, 2021. I HAD 2 DAYS OF 99 DEGREE TEMPERATURE. I LOST MY SENSE OF SMELL FOR TWO DAYS. MUCH LATER  I MISSED A PERIOD  IN SEPTEMBER 2021. LINGERING LOW ENERGY DURING WORKOUTS. ARM SORENESS  AT THE INJECTION SITE BACK IN MARCH 2021. THIS IS MY BEST GUESS FOR WHERE I CONTRACTED COVID : I BELIEVE I CONTRACTED IT ON THE EVEINGING ON JULY 3, 2021 AT AN INDOOR CONCERT VENUE WHERE THERE WAS NO MASK.
Severe swelling and pain in joints.  Cannot bend fingers or neck.  Severe pain in  neck.
This spontaneous report as received from a medical assistant refers to a multiple number of unspecified patients of unknown age and gender, who might have received a dose on an unknown date of GARDASIL (dose and lot # not reported), that was possibly exposed to 31 F for an unknown period of time. The medical assistant reported that she has 2 thermometers in her refrigerator where GARDASIL was stored. She mentioned that her mercury thermometer was reading 3 C and her digital thermometer was reading 31 F. The medical assistant did not know which thermometer reading was accurate. No other co-suspects were reported. No concomitant medications were reported. No adverse symptoms reported. No treatment information was reported. Additional information has been requested.
Approximately 6 months post vax the pt developed herpes zoster, with rhinorrhea, a cough and a fever of 101.5F. Pt had two patches of herpes zoster on the right side of her chest, both in the T6 and T7 dermatome. Her medial clusters were noted to be erythematous. Pt was treated with Augmentin  for superinfection and a suspect lesion on her right chest. Pts vesicular clusters were small.
felt very hot and faint, feeling of passing out, very anxious, happened after first dose as well. talked to patient and calmed her down
been giving pediatric doses of this vaccine to adults; been giving pediatric doses of this vaccine to adults; This case was reported by a other health professional via call center representative and described the occurrence of underdose in an unspecified number of patients who received DTPa (Infanrix) (batch number 23T73, expiry date 30th April 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced underdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the underdose and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at the vaccination was not applicable for this report. The reporter stated the number of patients were 58 as per his/her belief. No patient identifiers were reported. The reporter had one lot number to provide at this time, expiration date obtained from batch number identifier. The reporter stated that in a Chat with CCMA in reference to DTaP Infanrix, it came to his/her attention that out office had been giving pediatric doses of this vaccine to adults, which led to inappropriate age at vaccine administration and underdose. The reporter wanted to know how to report this and what was the recommendation to fix It. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.
Patient was observed post Covid-19 immunization for 15 minutes . Immediately after sitting down for the 15 minute observation, she reported her tongue started swelling. She was taken out by EMS for triage, she had hives to the back of neck, ears and her arms. BP 166/90, O2 sat RA 88% initially. She was given Benadryl 25 mg IM and Solumedrol 125 mg IV all by EMS and her O2 sat increased to 90's with last one 98%. She reported feeling better. Ambulance called and transported to ED for further evaluation.
Vomiting, Cheeks feel tingling, Slight difficulty swallowing.  Rest and will take oral Benadryl when gets home.  Will take Phenergan for nausea when gets home as well.  Starting to feel better after 2 hours.
Pain and stiffness in joints, stiff neck, muscle and body aches x 1 week.
Injection site on Left leg red. Redness is 4 cm x 3cm with a 1cm induration.
left side swelling in face and left arm, pain in left leg, developed approximately 36 hours after vaccination
9 days post immunization had complex febrile seizure, see attached report. EEG MRI pending.
This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Feb-2021 at 9:49 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Feb-2021 at 9:49 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The age of the patient was reported as 74.42. No concomitant medications were reported. On 17-Feb-2021, 5 vials were moved to clinic. For lot no. 022M20A, the vial was initially moved to the fridge on 11-Feb-2021 and proposed beyond use date was 13-Mar-2021. On the date of administration, at 08:00 A.M., the temperature recorded was 20 degree Fahrenheit and at 09:00 A.M., the temperature recorded was 22 degree Fahrenheit has been reached by the vial. The vaccine beyond use date was reported as 13-Mar-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. The healthcare professional (HCP) reported that, each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. The vial was stored in cooler storage during high-pace COVID-19 vaccination clinic at the time of excursion. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided. This case was linked to MOD-2022-566976 (Patient Link).
10-3-03 irritation right eye. 10-4-03 right eye draining (clear) drainage and numbness right side of lip. 10-6-03 saw doctor, assessment found symptoms consistent with bells's palsy. Rx'ed prednisone, 40 mg pobid x 3 days, 30 mg pobid x 3 days, 20 mg pobid x 3 days, 10 mg pobid x 3 days then dc. Valtrex 500 mg pobid x 7 days.  Flouresain dye right eye neg. corneal abrasion recheck in one month.
Severe heart palpitations, premature ventricular contractions, nonsustained ventricular tachycardia, supraventricular tachycardia, bradycardia, cardiomyopathy.
1 1/2 hrs p/vax pt started to shake & had a blank stare; lips turned blue, cheeks flushed, hands were cold & teeth were chattering; taken immed to clinic; was sleepy on way there; t103.5 R; probably had flu & bad cough;
I had a fever, cough, running nose, and fatigue. I also had a headache. These symptoms lasted for 3 day but the fatigue lasted for about a week. I went to the doctor about this. They did a Covid-19 test, positive results.